Bourgeon Capital Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-20,000
| Closed | -$72K | – | 250 |
|
|
2019
Q3 | $72K | Buy |
+20,000
| New | +$72K | 0.04% | 98 |
|
|
2019
Q1 | – | Sell |
-26,500
| Closed | -$42K | – | 82 |
|
|
2018
Q4 | $42K | Sell |
26,500
-16,000
| -38% | -$25.4K | 0.03% | 67 |
|
|
2018
Q3 | $156K | Buy |
42,500
+10,000
| +31% | +$36.7K | 0.08% | 73 |
|
|
2018
Q2 | $92K | Sell |
32,500
-2
| -0% | -$6 | 0.05% | 72 |
|
|
2018
Q1 | $121K | Sell |
32,502
-16,002
| -33% | -$59.6K | 0.07% | 71 |
|
|
2017
Q4 | $140K | Buy |
48,504
+19,004
| +64% | +$54.9K | 0.08% | 82 |
|
|
2017
Q3 | $132K | Sell |
29,500
-5,000
| -14% | -$22.4K | 0.08% | 82 |
|
|
2017
Q2 | $158K | Hold |
34,500
| – | – | 0.1% | 73 |
|
|
2017
Q1 | $145K | Hold |
34,500
| – | – | 0.09% | 81 |
|
|
2016
Q4 | $142K | Buy |
34,500
+13,000
| +60% | +$53.5K | 0.09% | 85 |
|
|
2016
Q3 | $174K | Sell |
21,500
-9,000
| -30% | -$72.8K | 0.11% | 84 |
|
|
2016
Q2 | $238K | Buy |
30,500
+9,000
| +42% | +$70.2K | 0.15% | 76 |
|
|
2016
Q1 | $166K | Buy |
21,500
+10,000
| +87% | +$77.2K | 0.11% | 86 |
|
|
2015
Q4 | $124K | Sell |
11,500
-49,200
| -81% | -$531K | 0.08% | 89 |
|
|
2015
Q3 | $419K | Sell |
60,700
-30,000
| -33% | -$207K | 0.29% | 65 |
|
|
2015
Q2 | $804K | Buy |
90,700
+35,600
| +65% | +$316K | 0.49% | 57 |
|
|
2015
Q1 | $543K | Buy |
55,100
+22,400
| +69% | +$221K | 0.33% | 65 |
|
|
2014
Q4 | $401K | Buy |
32,700
+12,700
| +64% | +$156K | 0.24% | 78 |
|
|
2014
Q3 | $200K | Buy |
+20,000
| New | +$200K | 0.12% | 99 |
|
|
2014
Q2 | – | Sell |
-30,000
| Closed | -$99K | – | 122 |
|
|
2014
Q1 | $99K | Buy |
+30,000
| New | +$99K | 0.06% | 92 |
|